|
Re: Share price - some thoughts
|
1
|
Resverlogix Corp.
|
Aug 01, 2017 03:07PM
|
|
Re: Statistical Considerations
|
1
|
Resverlogix Corp.
|
Mar 06, 2018 03:04PM
|
|
Question for the experts
|
1
|
Zenith Epigenetics
|
Oct 08, 2024 12:32PM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
1
|
Resverlogix Corp.
|
May 10, 2017 03:30PM
|
|
Re: Removing plaque article
|
1
|
Resverlogix Corp.
|
Jun 27, 2017 02:37PM
|
|
Re: SH
|
1
|
Resverlogix Corp.
|
Dec 28, 2015 10:19AM
|
|
Re: AGM - Jan 7, 2016 - Details
|
1
|
Zenith Epigenetics
|
Jan 12, 2016 10:50PM
|
|
Consequences of BETonMACE Findings
|
1
|
Resverlogix Corp.
|
May 10, 2016 01:26PM
|
|
Re: 5 million shares
|
1
|
Resverlogix Corp.
|
Sep 28, 2019 02:39PM
|
|
Re: Reports of Exempt Distribution
|
1
|
Zenith Epigenetics
|
Feb 24, 2023 10:39AM
|
|
Re: Question
|
1
|
Resverlogix Corp.
|
Feb 25, 2021 01:18PM
|
|
Re: Rock Stars still rocking it
|
1
|
Zenith Epigenetics
|
Jun 06, 2018 02:43PM
|
|
Re: Zenith MD&A posted to SEDAR 8/23/18
|
1
|
Zenith Epigenetics
|
Sep 01, 2018 01:23PM
|
|
Re: Statistical Considerations
|
1
|
Resverlogix Corp.
|
Mar 08, 2018 12:03PM
|
|
Re: Do tell Kelsee
|
1
|
Resverlogix Corp.
|
Dec 29, 2015 06:08PM
|
|
Re: The significance of the SSRA
|
1
|
Resverlogix Corp.
|
Jun 20, 2018 09:41AM
|
|
Re: Momentum
|
1
|
Resverlogix Corp.
|
Jul 31, 2018 04:19PM
|
|
Snow Job
|
1
|
Resverlogix Corp.
|
Dec 22, 2021 01:18PM
|
|
Re: time to add/3 vs 5 pt. MACE
|
1
|
Resverlogix Corp.
|
Mar 21, 2018 10:34PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
1
|
Zenith Epigenetics
|
Jul 19, 2017 04:00PM
|
